CRISPR Therapeutics AG earnings per share and revenue

CRSP earnings per share for the last quarter are 1.10 USD whereas the estimation was 0.07 USD which accounts for 1558.80% surprise. Company revenue for the same period amounts to 201.21 M USD despite the estimated figure of 140.94 M USD. Estimated earnings per share for the next quarter are -1.35 USD, and revenue is expected to reach 25.53 M USD. Also watch annual changes over time to get a bigger picture of CRSP earnings per share and revenue dynamics.